Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 6 (June)

1. Neuronal Peroxisome Proliferator-Activated Receptor gamma Signaling: Regulation by Mood-Stabilizer Valproate.
   J Mol Neurosci, 35(2): 225-34. [Abstract] [Full-text]
2. Emotional memory in bipolar disorder.
   Br J Psychiatry, 192(6): 458-63. [Abstract] [Full-text]
3. Executive dysfunction in elderly bipolar manic patients.
   Am J Geriatr Psychiatry, 16(6): 506-12. [Abstract] [Full-text]
4. Antidepressant-associated mania: soon after switch from fluoxetine to mirtazapine in an elderly woman with mixed depressive features.
   J Psychopharmacol. [Abstract] [Full-text]
5. Is valproate promising in cardiac fatal arrhythmias? Comparison of P- and Q-wave dispersion in bipolar affective patients on valproate or lithium-valproate maintenance therapy with healthy controls.
   J Psychopharmacol. [Abstract] [Full-text]
6. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
   Eur Neuropsychopharmacol, 18(7): 535-49. [Abstract] [Full-text]
7. Randomized study comparing postoperative pain between coblation and bipolar scissor tonsillectomy.
   Eur Arch Otorhinolaryngol, 265(7): 817-20. [Abstract] [Full-text]
8. Expression of cellular prion protein (PrP(c)) in schizophrenia, bipolar disorder, and depression.
   J Neural Transm, 115(5): 761-71. [Abstract] [Full-text]
9. G72 and its association with major depression and neuroticism in large population-based groups from Germany.
   Am J Psychiatry, 165(6): 753-62. [Abstract] [Full-text]
10. Role of an N-Terminal Splice Segment in the Activation of the Cation Channel TRPM2 by ADP-Ribose and Hydrogen Peroxide.
    Neurochem Res. [Abstract] [Full-text]
11. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    J Psychiatr Pract, 14(3): 160-9. [Abstract] [Full-text]
12. Genes and neuroimaging: advances in psychiatric research.
    Neurodegener Dis, 5(5): 277-85. [Abstract] [Full-text]
13. Editorial review: Shifting views on juvenile bipolar disorder and pervasive developmental disorder.
    Curr Opin Psychiatry, 21(4): 328-31. [Abstract] [Full-text]
14. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    South Med J, 101(6): 639-40. [Abstract] [Full-text]
15. The PDLIM5 gene and lithium prophylaxis: An association and gene expression analysis in Sardinian patients with bipolar disorder.
    Pharmacol Res, 57(5): 369-73. [Abstract] [Full-text]
16. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
17. Photopic ON- and OFF-responses in complete type of congenital stationary night blindness in relation to stimulus intensity.
    Doc Ophthalmol, 117(1): 37-46. [Abstract] [Full-text]
18. Effect of chronic lithium treatment on D2/3 autoreceptor regulation of dopaminergic function in the rat.
    Pharmacol Biochem Behav, 90(2): 218-25. [Abstract] [Full-text]
19. Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Ann Epidemiol, 18(6): 458-66. [Abstract] [Full-text]
20. Oxidative stress markers in bipolar disorder: A meta-analysis.
    J Affect Disord. [Abstract] [Full-text]
21. The phenomenology of recurrent brief depression with and without hypomanic features.
    J Affect Disord. [Abstract] [Full-text]
22. Prevalence and correlates of physical and sexual abuse in children and adolescents with bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
23. Functional Analysis of a Potassium-Chloride Co-Transporter 3 (SLC12A6) Promoter Polymorphism Leading to an Additional DNA Methylation Site.
    Neuropsychopharmacology. [Abstract] [Full-text]
24. Quantitative analysis of the 4977-bp common deletion of mitochondrial DNA in postmortem frontal cortex from patients with bipolar disorder and schizophrenia.
    Neurosci Lett, 439(2): 173-7. [Abstract] [Full-text]
25. Association between depression and the Gln460Arg polymorphism of P2RX7 Gene: A dimensional approach.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
26. Psychopharmacological treatment before suicide attempt among patients admitted to a Psychiatric Intensive Care Unit.
    J Affect Disord. [Abstract] [Full-text]
27. Mitochondrial DNA haplogroup analysis in patients with bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
28. The copy number variant involving part of the alpha7 nicotinic receptor gene contains a polymorphic inversion.
    Eur J Hum Genet. [Abstract] [Full-text]
29. Counselor and Client Characteristics in Mental Health versus Substance Abuse Treatment Settings Providing Services for Co-Occurring Disorders.
    Community Ment Health J, 44(3): 155-69. [Abstract] [Full-text]
30. Usefulness of the Spanish version of the mood disorder questionnaire for screening bipolar disorder in routine clinical practice in outpatients with major depression.
    Clin Pract Epidemol Ment Health, 4: 14. [Abstract] [Full-text]
31. Shared Neurocognitive Dysfunctions in Young Offspring at Extreme Risk for Schizophrenia or Bipolar Disorder in Eastern Quebec Multigenerational Families.
    Schizophr Bull. [Abstract] [Full-text]
32. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder.
    Cell Calcium, 44(1): 92-102. [Abstract] [Full-text]
33. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Psychiatry Res, 160(1): 47-54. [Abstract] [Full-text]
34. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Psychiatry Res, 160(1): 55-62. [Abstract] [Full-text]
35. Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial.
    Psychiatry Res, 160(1): 63-71. [Abstract] [Full-text]
36. The misdiagnosis of bipolar disorder as a psychotic disorder: Some of its causes and their influence on therapy.
    J Affect Disord. [Abstract] [Full-text]
37. Attitudes to genetic testing in families with multiple cases of bipolar disorder.
    Genet Test, 12(2): 233-43. [Abstract] [Full-text]
38. Clinical trial of wellness training: health promotion for severely mentally ill adults.
    J Nerv Ment Dis, 196(6): 475-83. [Abstract] [Full-text]
39. Caregiver burden and health in bipolar disorder: a cluster analytic approach.
    J Nerv Ment Dis, 196(6): 484-91. [Abstract] [Full-text]
40. Suicidality and its association with insight and neurocognition in taiwanese patients with bipolar I disorder in remission.
    J Nerv Ment Dis, 196(6): 462-7. [Abstract] [Full-text]
41. Relationship between insight and neurocognition in patients with bipolar I disorder in remission.
    Compr Psychiatry, 49(4): 335-9. [Abstract] [Full-text]
42. Mental disorder and threats made by noninstitutionalized people with weapons in the national comorbidity survey replication.
    J Nerv Ment Dis, 196(6): 437-45. [Abstract] [Full-text]
43. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function.
    Mol Psychiatry, 13(7): 685-96. [Abstract] [Full-text]
44. The treated prevalence and incidence of bipolar disorder among national health insurance enrollees in Taiwan, 1996-2003.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
45. Psychiatric genetics: progress amid controversy.
    Nat Rev Genet, 9(7): 527-40. [Abstract] [Full-text]
46. Association of tumor necrosis factor -308G/A promoter polymorphism with schizophrenia and bipolar affective disorder in a Polish population.
    Neuropsychobiology, 57(1): 88-94. [Abstract] [Full-text]
47. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1331-7. [Abstract] [Full-text]
48. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: Possible association with higher occurrence in bipolar disorder patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1214-20. [Abstract] [Full-text]
49. Smoking in Schizophrenia: Diagnostic Specificity, Symptom Correlates, and Illness Severity.
    Schizophr Bull. [Abstract] [Full-text]
50. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1199-205. [Abstract] [Full-text]
51. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(5): 1195-8. [Abstract] [Full-text]
52. Shared gene expression alterations in schizophrenia and bipolar disorder.
    Biol Psychiatry, 64(2): 89-97. [Abstract] [Full-text]
53. Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward task.
    Biol Psychiatry, 64(2): 162-8. [Abstract] [Full-text]
54. Promoter variant in the GRK3 gene associated with bipolar disorder alters gene expression.
    Biol Psychiatry, 64(2): 104-10. [Abstract] [Full-text]
55. Association analysis of monoamine oxidase A gene and bipolar affective disorder in Han Chinese.
    Behav Brain Funct, 4: 21. [Abstract] [Full-text]
56. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
    Neurosci Lett, 440(2): 150-4. [Abstract] [Full-text]
57. A 7 Mb duplication at 22q13 in a girl with bipolar disorder and hippocampal malformation.
    Am J Med Genet A, 146(13): 1754-60. [Abstract] [Full-text]
58. Reasons for substance use in dual diagnosis bipolar disorder and substance use disorders: A qualitative study.
    J Affect Disord. [Abstract] [Full-text]
59. Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia.
    Brain Res, 1218: 267-77. [Abstract] [Full-text]
60. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Exp Cell Res, 314(11): 2279-88. [Abstract] [Full-text]
61. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
    Neurosci Res, 61(4): 351-9. [Abstract] [Full-text]
62. Novel linkage to chromosome 20p using latent classes of psychotic illness in 270 Irish high-density families.
    Biol Psychiatry, 64(2): 121-7. [Abstract] [Full-text]
63. Family-based SNP association study on 8q24 in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 147(5): 612-8. [Abstract] [Full-text]
64. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: A combined twin and family study.
    Am J Med Genet B Neuropsychiatr Genet, 147(5): 619-27. [Abstract] [Full-text]
65. Involvement of the role of Chk1 in lithium-induced G2/M phase cell cycle arrest in hepatocellular carcinoma cells.
    J Cell Biochem, 104(4): 1181-91. [Abstract] [Full-text]
66. Elucidating semantic disorganisation from a word comprehension task: Do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?
    Schizophr Res, 102(1): 63-68. [Abstract] [Full-text]
67. Analysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.
    Schizophr Res, 102(1): 210-9. [Abstract] [Full-text]
68. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
69. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase.
    Mol Psychiatry. [Abstract] [Full-text]
70. Menstrual cycle dysfunction associated with neurologic and psychiatric disorders: their treatment in adolescents.
    Ann N Y Acad Sci, 1135: 219-29. [Abstract] [Full-text]
71. Prevalence and correlates of bipolar II disorder in major depressive patients at a psychiatric outpatient clinic in Hong Kong.
    J Affect Disord. [Abstract] [Full-text]
72. "I actually don't know who I am": the impact of bipolar disorder on the development of self.
    Psychiatry, 71(2): 123-33. [Abstract] [Full-text]
73. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Hum Psychopharmacol, 23(5): 417-24. [Abstract] [Full-text]
74. BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments.
    Proc Natl Acad Sci U S A, 105(25): 8766-71. [Abstract] [Full-text]
75. The Art of Prescribing Pharmacological Management of Adult ADHD: Implications for Psychiatric Care.
    Perspect Psychiatr Care, 44(3): 196-201. [Abstract] [Full-text]
76. The generalized anxiety spectrum: prevalence, onset, course and outcome.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
77. Postoperative complications in the seriously mentally ill: a systematic review of the literature.
    Ann Surg, 248(1): 31-8. [Abstract] [Full-text]
78. New-onset psychiatric disorders in individuals with autism.
    Autism, 12(4): 373-90. [Abstract] [Full-text]
79. Serum homocysteine levels and cognitive functioning in euthymic bipolar patients.
    J Affect Disord. [Abstract] [Full-text]
80. Psychosis and autism as diametrical disorders of the social brain.
    Behav Brain Sci, 31(3): 241-61; discussion 261-320. [Abstract] [Full-text]
81. Social support and adaptation of Taiwanese adults with mental illness.
    J Clin Nurs, 17(13): 1795-802. [Abstract] [Full-text]
82. Lithium toxicity precipitated by profound hypothyroidism.
    Thyroid, 18(6): 651-4. [Abstract] [Full-text]
83. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.
    Acta Psychiatr Scand, 118(1): 4-18. [Abstract] [Full-text]
84. Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series.
    J Psychopharmacol. [Abstract] [Full-text]
85. Models of mania and antimanic drug actions: progressing the endophenotype approach.
    J Psychopharmacol. [Abstract] [Full-text]
86. Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
87. Bipolar pathophysiology and development of improved treatments.
    Brain Res. [Abstract] [Full-text]
88. Correlates of subjective and objective burden among caregivers of patients with bipolar disorder.
    Acta Psychiatr Scand, 118(1): 49-56. [Abstract] [Full-text]
89. Comorbidity of conduct disorder and bipolar disorder in clinically referred children and adolescents.
    J Child Adolesc Psychopharmacol, 18(3): 271-9. [Abstract] [Full-text]
90. Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.
    Schizophr Bull, 34(4): 743-59. [Abstract] [Full-text]
91. Psychosis endophenotypes in schizophrenia and bipolar disorder.
    Schizophr Bull, 34(4): 720-1. [Abstract] [Full-text]
92. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.
    Schizophr Bull, 34(4): 760-73. [Abstract] [Full-text]
93. Approaches for unraveling the joint genetic determinants of schizophrenia and bipolar disorder.
    Schizophr Bull, 34(4): 791-7. [Abstract] [Full-text]
94. Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.
    Curr Med Res Opin. [Abstract] [Full-text]
95. Medical emergency department utilization patterns among uninsured patients with psychiatric disorders.
    Psychiatr Serv, 59(7): 808-11. [Abstract] [Full-text]
96. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial.
    Psychiatr Serv, 59(7): 760-8. [Abstract] [Full-text]
97. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder.
    Psychiatr Serv, 59(7): 753-9. [Abstract] [Full-text]
98. Personality traits in children of parents with unipolar and bipolar mood disorders.
    J Affect Disord. [Abstract] [Full-text]
99. N-Methyl-D-Aspartate Receptor and Calbindin-Containing Neurons in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder.
    Biol Psychiatry. [Abstract] [Full-text]
100. Metabolic syndrome in Italian patients with bipolar disorder.
     Gen Hosp Psychiatry, 30(4): 318-23. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.